Scant evidence, because the Phase 3 trial has not read out yet and no one else is using MLCs for CLBP, but you could take a look at the 2 or 3 year follow up on the Phase 2 trial for the same indication, you might find that illuminating.
Also, who are the Experts referenced in the article, can you provide their names, just for those of us who have no subscription.
Scant evidence, because the Phase 3 trial has not read out yet...
-
- There are more pages in this discussion • 6,494 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.010(1.09%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 90.5¢ | 94.0¢ | 89.5¢ | $4.970M | 5.436M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18877 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 6795 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |